Drug
HP828-101
HP828-101 is a pharmaceutical drug with 6 clinical trials. Historical success rate of 75.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
75.0%
Based on 3 completed trials
Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
133%(4 trials)
Terminated
1(17%)
Phase Distribution
Ph early_phase_1
2
33%
Ph not_applicable
1
17%
Ph phase_1
2
33%
Ph phase_2
1
17%
Phase Distribution
4
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution6 total trials
Early Phase 1First-in-human
2(33.3%)
Phase 1Safety & dosage
2(33.3%)
Phase 2Efficacy & side effects
1(16.7%)
N/ANon-phased studies
1(16.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
50.0%
3 of 6 finished
Non-Completion Rate
50.0%
3 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(3)
Terminated(3)
Detailed Status
Completed3
Withdrawn2
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
75.0%
Most Advanced
Phase 2
Trials by Phase
Early Phase 12 (33.3%)
Phase 12 (33.3%)
Phase 21 (16.7%)
N/A1 (16.7%)
Trials by Status
terminated117%
withdrawn233%
completed350%
Recent Activity
0 active trials
Showing 5 of 6
completedphase_1
Contact Sensitization Potential of 828 Ointment
NCT00767676
completedphase_1
Cumulative Irritation Potential of 828 Ointment
NCT00767455
completednot_applicable
Evaluation of the Effects of HP828-101 Versus Standard of Care in the Management of Partial or Full Thickness Wounds
NCT00971048
terminatedearly_phase_1
Evaluation of Effects of HP828-101 for Moisture Associated Skin Damage
NCT01108523
withdrawnearly_phase_1
Post Treatment Care After Chemical Peel or Laser Resurfacing
NCT01135290
Clinical Trials (6)
Showing 6 of 6 trials
NCT00767676Phase 1
Contact Sensitization Potential of 828 Ointment
NCT00767455Phase 1
Cumulative Irritation Potential of 828 Ointment
NCT00971048Not Applicable
Evaluation of the Effects of HP828-101 Versus Standard of Care in the Management of Partial or Full Thickness Wounds
NCT01108523Early Phase 1
Evaluation of Effects of HP828-101 for Moisture Associated Skin Damage
NCT01135290Early Phase 1
Post Treatment Care After Chemical Peel or Laser Resurfacing
NCT01273428Phase 2
HP011-101, HP828-101, and Standard Care for Pressure Ulcers
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6